| Literature DB >> 17935916 |
Nina Donauer1, Raimar Löbenberg.
Abstract
Disintegration is a performance test for oral dosage forms that is described in the United States Pharmacopeia (USP), the European Pharmacopeia (EP) and the Japanese Pharmacopeia (JP, chapter 14, 2001). This review lists changes that have been made since the USP 23 and compares them to those in the USP 30, EP 5.3 and JP XIV. The differences between the disintegration test methods in the three pharmacopeias are discussed. Examples are provided where disintegration can be used as a performance test for ensuring the drug release.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17935916 DOI： 10.1016/j.ijpharm.2007.08.045
Source DB: PubMed Journal: Int J Pharm ISSN： 0378-5173 Impact factor: 5.875